DP3 Stock Overview
Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Central Pharmaceutical Joint Stock Company No3 Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫57,900.00 |
| 52 Week High | ₫77,000.00 |
| 52 Week Low | ₫57,500.00 |
| Beta | 0.31 |
| 11 Month Change | -3.02% |
| 3 Month Change | -8.24% |
| 1 Year Change | -9.53% |
| 33 Year Change | 23.72% |
| 5 Year Change | 87.99% |
| Change since IPO | 589.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| DP3 | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | -0.2% | 1.5% | 0.7% |
| 1Y | -9.5% | 21.7% | 9.9% |
Return vs Industry: DP3 underperformed the VN Pharmaceuticals industry which returned 21.7% over the past year.
Return vs Market: DP3 underperformed the VN Market which returned 9.9% over the past year.
Price Volatility
| DP3 volatility | |
|---|---|
| DP3 Average Weekly Movement | 1.7% |
| Pharmaceuticals Industry Average Movement | 3.3% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in VN Market | 6.6% |
| 10% least volatile stocks in VN Market | 1.8% |
Stable Share Price: DP3 has not had significant price volatility in the past 3 months compared to the VN market.
Volatility Over Time: DP3's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | n/a | n/a | www.duocphamtw3.com |
Central Pharmaceutical Joint Stock Company No3 engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. The company offers medicines from medicinal herbs; pharmaceutical drugs; food that protects health products; and medical equipment; as well as cosmetics products. It is involved in the production and testing of drugs; growing spices and medicinal plants; production of functional foods; distilling and blending of spirits; production of non-alcoholic beverages and mineral water; and manufacturing of soaps, detergents, polishes, and toilet preparations.
Central Pharmaceutical Joint Stock Company No3 Fundamentals Summary
| DP3 fundamental statistics | |
|---|---|
| Market cap | ₫1.24t |
| Earnings (TTM) | ₫119.19b |
| Revenue (TTM) | ₫395.21b |
10.4x
P/E Ratio3.1x
P/S RatioIs DP3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DP3 income statement (TTM) | |
|---|---|
| Revenue | ₫395.21b |
| Cost of Revenue | ₫126.63b |
| Gross Profit | ₫268.58b |
| Other Expenses | ₫149.39b |
| Earnings | ₫119.19b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.54k |
| Gross Margin | 67.96% |
| Net Profit Margin | 30.16% |
| Debt/Equity Ratio | 0% |
How did DP3 perform over the long term?
See historical performance and comparison